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Introduction
Developments in the management of critically ill patients have led to a significant increase in survival rates and the emergence of numerous sequels, such as intensive care unit-acquired weakness (ICUAW). The presence of critical illness polineuropathy and critical illness myopathy is the major cause of ICUAW [1] . Intensive care unit-acquired weakness is characterized by a decrease in the neuromuscular excitability, generalized muscle weakness, and difficult weaning from mechanical ventilation [2] . The development of ICUAW is associated with high morbidity and mortality and prolonged intensive care unit (ICU) stay. Therefore, some strategies have been suggested to avoid ICUAW [3] .
Neuromuscular electrical stimulation (NMES) has been considered an alternative for the prevention of ICUAW [4, 5] . However, there is no consensus about the best NMES parameters to be used, such as total charge, motor point localization, and neuromuscular excitability threshold [6] . Total charge is the product of pulse width and pulse frequency [7] . It would directly influence NMES efficiency because the greater is the charge in the muscle, the higher is the evoked peak torque [7] . Motor point (ie, the most excitable area over the muscle) and neuromuscular excitability thresholds are of paramount importance for NMES efficiency. They are detected during stimulus electrodiagnosis tests [8, 9] . Once active electrode is placed over motor point, lower pulse intensity is necessary to evoke torque [8] . The correlation between pulse intensity and pain sensation is already demonstrated [10] . Because pain produced during NMES is one major limiting factor for evoked torque production, motor point should be carefully located.
Stimulus electrodiagnosis test allows for the acquisition of motor excitability thresholds (rheobase and chronaxie). Chronaxie has a key role in the NMES treatment for patients with neuromuscular disorders [11, 12] . It is the shortest pulse width to produce a minimal muscle contraction with intensity equal twice the rheobase [9] . Rheobase is the minimal intensity necessary to reach neuromuscular excitability threshold with infinite pulse width [13] . Typical values of chronaxie ranged from 60 to 1000 microseconds [9, 14] . Neuromuscular electrical stimulation protocols with pulse width shorter than chronaxie will generate insufficient stimulation with reduced peak torque.
To date, all studies in ICU used NMES protocols without concern for neuromuscular excitability or total charge [4, 5, 11, [15] [16] [17] [18] [19] [20] [21] [22] . Although some studies have found favorable outcome with the use of NMES, others were not able to demonstrate the same results [23] [24] [25] . It might be related to the different protocols used and to the lack of neuromuscular excitability assessments. Pulse widths used in these studies ranged from 250 to 500 microseconds, which might have been insufficient to generate maximal evoked torque for patients with neuromuscular electrophysiological disorders [17, 18, 26] . Beyond that, the number of stimulated muscle groups might have interfered in the results. Different from orthopedic settings with one limb immobilized and exposed to atrophy, critical ill patients are undergoing bed rest. Thus, they are subjected to generalized atrophy and loss of muscle strength. Therefore, the largest possible part of the body should be stimulated. However, the higher the evoked peak torque is and the greater the number of stimulated muscle is, the higher the metabolic burden and muscle damage will be.
The safety of an NMES protocol based on neuromuscular excitability (possible high total charge values) applied on numerous muscle groups has never been investigated in critical ill patients. Thus, the aim of this research was to evaluate the safety and feasibility of a personalized NMES protocol performed sequentially in 5 muscle groups in critically ill patients undergoing mechanical ventilation. Our hypothesis was that the proposed NMES protocol would be safe, not promoting disturbance in the relationship between supply and oxygen consumption and neuromuscular harms.
Materials and methods
An observational, prospective study was carried out from February to July 2013 in the ICU of a tertiary public hospital in Teresina, Brazil.
The protocol was approved by local ethics committee in compliance with the Declaration of Helsinki (number 59/12). All legally responsible for the patients signed a free and informed consent form before the research. Patients were consecutively admitted and NMES was applied daily for 3 days. This period was chosen because the first days of NMES are more critical to produce muscle damage [27] . Central venous oxygen saturation (SvcO 2 ) and blood lactate were measured immediately before and after each NMES session. The blood level of creatine phosphokinase (CPK) was measured at the first day (before the first bout of NMES) and every day up to 96 hours after the first bout.
The study included individuals older than 18 years, both sexes, with Acute Physiology and Chronic Health Evaluation II score higher than 13, under mechanical ventilation from 24 to 48 hours with prediction to stay in mechanical ventilation for, at least, 3 days by the senior ICU physician on admission [28] . Patients with hemodynamic instability [29] (mean arterial blood pressure b65 or N110 mm Hg), with lesions on the skin that prevent the realization of our protocol, and/or with fractures in lower limbs were excluded.
Assessment of neuromuscular excitability
The chronaxie and rheobase assessments were performed with the universal pulse generator Dualpex 071 (Quark Medical, Piracicaba, Brazil), in 5 muscle groups using 9 × 5 cm carbon electrodes. The location of the electrodes and the muscle groups are shown in Fig. 1 . The electrode placement sites were based on areas of greatest excitability, as described previously [8] . All areas were shaved and the location of each electrode was marked with high-fixation ink pen to avoid positioning changes over days. All patients had local temperatures higher than 33°C as recommended previously [30] . For rheobase measurement, the current was increased from 0 to 69 mA in 1-mA increments until there was a slight but clearly visible muscle contraction. Stimulation was performed with a bipolar rectangular pulse, with pulse width of 1 second and a rest interval of 2 seconds [9] . For chronaxie measurement, bipolar rectangular pulse was used. The pulse width was increased from 20 microseconds to 1 second in 100-microsecond increments until 1000 microseconds and then by 1000-microsecond increments until there was a slight but clearly visible muscle contraction [9] .
Neuromuscular electrical stimulation protocol
Based on chronaxie and rheobase assessed daily, an NMES protocol was performed once a day for 15 minutes (90 contractions), pulse Fig. 1 . Placement of electrodes. A, Gluteus maximus; motor area of the gluteus maximus: just below and lateral iliac edge and medial and superior insertion of the gluteus at iliotibial tract. B, Hamstrings; motor area of the hamstrings: proximal third and distal third of the muscle bundle. C, Quadriceps femoris; motor medial vast area: proximal and distal third of the muscle bundle; motor area of the vastus lateralis: proximal and distal third of the muscle bundle. D, Gastrocnemius; motor area of the triceps surae: proximal third and distal third of the muscle bundle. E, Tibialis anterior; motor zone of the tibialis anterior: proximal third and distal third of the muscle belly (anterolateral tibia). We used in all muscles electrodes with dimensions of 9 × 5 cm.
width equal to chronaxie, pulse frequency of 100 Hz, ON time 5 seconds, OFF time of 5 seconds, no rise time, and decay. Current intensity was standardized and fixed from the higher visible muscle contraction. During NMES protocols, all patients were sedated, but some of them expressed facial pain, which precluded the increment of current intensity. No warm-up or cool-down were performed. Neuromuscular electrical stimulation sessions were performed sequentially in 3 times in a total time of 45 minutes, due to the limitation of available channels (4) in the stim unit. Therefore, NMES was applied in the same order bilateral as follow: gluteus maximus (channels 1 and 2) and gastrocnemius (channels 3 and 4) simultaneously; then, we performed NMES on tibialis anterior (channels 1 and 2) and hamstrings (channels 3 and 4) simultaneously; and finally, the quadriceps femoris a part (channels 1, 2, 3 and 4).
Blood sample assessment
To evaluate the relationship between supply and oxygen consumption, blood levels of lactate and SvcO 2 were considered. The degree of muscle damage was assessed indirectly with CPK levels. For this, 2 mL blood samples were daily collected from central venous access and assayed in duplicate before and immediately after the last muscle groups being stimulated. These variables were measured with blood analyzer systems Cobas C501 and Cobas b 221 (Roche, Basel, Switzerland). If the difference of duplicate samples was greater than 10%, new samples were carried out. The reference values for healthy subjects established by the manufacturer for lactate, SvcO 2 , and CPK (for men) were, respectively, 0.5 to 2.2 mmol/L, 70% to 80%, and up to 190 IU/L. SvcO 2 and lactate were analyzed every day, before and immediately after NMES application, during 3 consecutive days. The levels of CPK were measured at baseline (before the first bout) and every 24 hours up to 96 hours.
Feasibility
To assess the feasibility of the present protocol, we recorded the time spent to perform the entire NMES protocol (electrode positioning, stimulus electrodiagnosis test, and NMES in all 5 muscle groups). Moreover, we measured the number of NMES sessions completely performed and the number of NMES with visible muscle contraction.
Statistical analysis
For presentation of sample characteristics, a descriptive analysis of the data was performed. Data normality was tested using the ShapiroWilk test. Variables were presented as mean ± SD. The sphericity of repeated measures was corrected by Geisser-Greenhouse Correction. For the analysis of changes in serum lactate and SvcO 2 , Wilcoxon rank test was used once these variables showed nonparametric behavior. The evaluation of CPK variation over the days was performed using repeated-measures analysis of variance (ANOVA) corrected for multiple comparisons by Tukey post hoc test. To test the hypothesis of chronaxie variation between different muscles and for the same muscle over the days, we used ANOVA 1-way and repeated-measures ANOVA, respectively, corrected for multiple comparison by Tukey post hoc test. All conclusions were based on a significance level of 5%. The power calculation of the sample was post hoc conducted with GPower software (version 3.1.3; Kiel University, Kiel, Germany). All analyses were performed with Graphpad Prism software (version 6; Graphpad Software, Inc, San Diego, California, USA).
Results
Eleven male patients (39 ± 16 years old) were analyzed at the end of the study. The flow diagram is shown in Fig. 2 and the characteristics of the patients in Table 1 . This sample size presented a power 1 − β N 0.80 for the major parameters (CPK, SvcO 2 , and blood lactate).
Eighty-four (85%) of the total possible 99 NMES sessions were completed. The contraction characteristics were evaluated visually and it was present 100% of the time. At the end of every NMES 15-minute session, all patients showed fatigue with decreased contraction intensity. The total duration of every complete procedure (including time spent in electrode positioning, stimulus electrodiagnosis test, and NMES sessions of all muscles) was 107 ± 24 minutes. All these data are compiled in Table 2 .
The total charge applied over days at all muscles had a mean (±SD) of 45 000 (±17 000) V * s −6 with maximal of 70 000 V * s
. The mean intensity (±SD) was 56 (±15) mA for gluteus maximus, 55 (±13) mA for quadriceps femoris, 52 (±13) mA for hamstrings, 57 (±13) mA for tibialis anterior, and 57 (±11) mA for gastrocnemius.
Chronaxie assessments were performed in all muscles at every session. General mean (±SD) values during the 3 days were 550 (±170) microseconds for gluteus maximus, 500 (±200) microseconds for quadriceps femoris, 450 (±150) microseconds for hamstrings, 550 (±150) microseconds for tibialis anterior, and 450 (±150) microseconds for gastrocnemius. There was a significant difference between the chronaxies of some muscles at day 1: gluteus maximus: 550 (±150) microseconds vs quadriceps: 300 (±90) microseconds; quadriceps: 300 (±90) microseconds and tibialis anterior: 540 (±160) microseconds, respectively (P = .005 and P = .005). The comparisons of intermuscle groups over day 2 and day 3 did not demonstrate any significant differences. Considering intragroup comparisons, chronaxies did not vary significantly for the same muscle over days: gluteus maximus, P = .44; quadriceps femoris, P = .35; hamstrings, P = .77; tibialis anterior, P = .09; and gastrocnemius, P = .89. These data are shown in Fig. 3 .
There were no significant changes in CPK levels along the study. (Fig. 4) . Serum lactate levels were not significantly different after NMES in the day 1, day 2, and day 3 with P = .8, P = .6, and P = .9, respectively (Fig. 5A) . The values of SvcO 2 were not modified in day 1 and day 2 before and after NMES (P = .23 and P = .24 respectively). However, in day 3, there was a significant change, P = .01 (Fig. 5B) . No patient showed burns caused by the present NMES protocol.
Discussion
The present study showed that an NMES protocol performed in various muscle groups and based on neuromuscular excitability was safe with no harmful muscle damage or disturbance of the relationship between supply and oxygen consumption. The present protocol, despite being a time-demanding procedure, was feasible with more than 80% of success session as well 100% of visible evoked muscle contraction. Moreover, because of the significant variation found in chronaxie values in different muscles, the necessity to assess neuromuscular excitability in critically ill patients was demonstrated. This can help establishing more effective NMES protocols [11, 31, 32] .
In the present study, skeletal muscle damage was assessed indirectly by blood CPK levels. Any significant variation on CPK levels over days after NMES protocol was not found. The increase in CPK levels after NMES is well documented in healthy subjects [33] . However, studies differ on the magnitude of the variation. Some research has shown that this increase is not significant [34, 35] . However, the study by Jubeau et al [27] found serum CPK levels higher than 3000 IU/L in peak damage (after 3 days of NMES). Guarascio et al [36] reported a case of rhabdomyolysis after NMES and suggested caution in introducing this type of therapy in rehabilitation. There is evidence that damage caused by artificial electrical muscle contraction is equivalent to damage caused by active eccentric contractions and the same care should be taken to avoid overtraining [33, 37] . Serum CPK from 5000 IU/L indicates serious muscle damage [38] . Kahanov et al [39] detected levels of CPK N 600 IU/L in athletes during conventional training (no NMES) and advocated that levels of 1000 IU/L or lower can be accepted safely.
In accordance with our findings, all randomized controlled trials of NMES in critical ill patients published so far demonstrated the safety of NMES [4, 5, [15] [16] [17] [18] [19] [20] [21] [22] . Some authors demonstrated that metabolic responses measured for SvcO 2 , serum lactate, and CPK had no hazardous variations after NMES protocols [40, 41] . The present study is in accordance with these findings. A significant difference in SvcO 2 at day 3 was found, but it was due to an increase in SvcO 2 after NMES. One possible physiological mechanism to explain it might be related to the improvement in peripheral circulation. This is supported by Gerovasili at al [40] , who demonstrated NMES effect on systemic microcirculation. To our knowledge, this is the first study to evaluate the safety and feasibility of NMES on more than 4 muscular groups and with a high total charge (until 70 000 V * s −6 ) with an average intensity of 55 ± 13
mA. Routsi et al [4] , for example, used a total charge of 18 000 V * s
and mean intensity of 38 ± 10 mA. Most of the studies stimulated only quadriceps femoris and/or tibialis anterior muscles [4, 5, [15] [16] [17] [18] [19] [20] [21] [22] . Only one research stimulated 4 muscle groups in comatose patients for 6 weeks [41] . Quadriceps femoris, hamstring, gastrocnemius, and tibialis anterior muscles were stimulated, daily for 30 minutes. The authors showed that NMES decreased muscle atrophy with no adverse effects. However, NMES characteristics (ie, the dose) were not presented [41] . The definition of the adjustments of our NMES protocol was based on previous recommendations [6] . The study by Peviani et al [42] showed that NMES based on chronaxie and rheobase was safe and effective in promoting anabolism of gene expression in mice with impaired neuromuscular excitability. Recently, this was confirmed in humans with denervated tibialis anterior muscle using a personalized NMES protocol based on chronaxie [11] . Stimulus electrodiagnosis test allows for the acquisition of chronaxie that has a key role in the NMES treatment for patients with neuromuscular electrophysiological disorders [11, 31] . Chronaxie is the shortest pulse width to produce a minimal muscle contraction with intensity equal to twice the rheobase [9] . Thus, NMES protocols with pulse width shorter than chronaxie will generate insufficient stimulation with reduced peak torque. Moreover, chronaxie measurement implies motor point localization [8, 9] . Motor point (ie, the most excitable area over the muscle) is also of paramount importance for NMES efficiency. Once active electrode is placed on Fig. 3 . Chronaxies values for every muscle for days. This figure presents chronaxies values for a day for every muscle. Considering intragroup comparisons, chronaxies did not vary significantly over days: gluteus maximus, P = .44; quadriceps femoris, P = .35; tibialis anterior, P = .09; hamstrings, P = .77; and gastrocnemius, P = .89. Fig. 4 . Change in CPK levels after 3 consecutive days of NMES bouts up to 96 hours after the first bout. At the baseline, CPK levels were analyzed before the first NMES protocol. After this time (still in baseline), NMES protocol was applied. Two more bouts were performed 24 and 48 hours after the first bout. At 72 and 96 hours, there are no NMES applications. Repeated-measures ANOVA with Tukey post hoc, P ≥ .99. motor point, lower pulse intensity is necessary to evoke torque [8] . The correlation between pulse intensity and pain sensation is already demonstrated [10] . Because pain produced during NMES is one major limiting factor for evoked torque production, motor point should be carefully located.
The efficiency of NMES, measured through electrically evoked torque, is generally expressed as a fraction of maximum voluntary contraction peak torque [43] . Thus, muscular strength gains induced by electrical stimuli are directly related to the degree of stress imposed by the artificial contractions [44] . The study by Gregory et al [7] demonstrated that torque is greatly influenced by the product of pulse width and pulse frequency, which is called total charge. These authors found, in healthy subjects, higher torque values on quadriceps femoris muscle when total charge reached 35 000 V * s −6 for a given preset voltage. The various combinations of settings in that study ranged from 20 to 100 Hz and 200 to 600 microseconds of pulse width. In individuals with impaired neuromuscular excitability, evoked torque based on the total charge has not been established. However, it can be inferred that higher values of total charge should be applied to evoke maximal peak torque. In healthy subjects, chronaxie ranged from 60 to 1000 microseconds [9, 14] , whereas in patients with neuromuscular electrophysiological disorders, values greater than 10 000 microseconds could be obtained [9, 11, 12] . Recently, Segers et al [26] have introduced the concept of responders and nonresponders to NMES in the ICU. These authors used a protocol with a peak pulse width, frequency, and intensity of 500 microseconds, 50 Hz, and 65 ± 8 mA, respectively (the total charge of 25 000 V * s −6 ). In this study, over days some patients failed to respond adequately to electrical stimuli and were called nonresponders. Reduced muscle contractile response to NMES in critical ill patients had been previously reported by Rodriguez et al [5] . These findings reinforce the necessity to assess neuromuscular excitability to apply electrical stimuli capable of generating significant torque. In patients with decreased neuromuscular excitability, chronaxie values are high. To generate forceful contractions, it is necessary to adjust larger pulse widths [11, 45] . We did not observe any change of the neuromuscular excitability, which is defined as chronaxie higher than 1000 microseconds [9] . However, in some patients, we found chronaxies up to 700 microseconds. This showed values higher than 400 microseconds often used in most published trials [4, 5, [15] [16] [17] [18] [19] [20] [21] [22] . Chronaxie also demonstrated some variability between muscles at day 1. In addition, our results suggested some consistencies because values were not statistically different over days. Because of a P value close to a significant level in tibialis anterior muscle, these measurements should be replicated and confirmed in a larger sample size and/or over a longer period. Taken as a whole, these results reinforce the necessity to personalize NMES characteristics. Dow et al [46] showed the necessity of 300 to 800 contractions equally divided for 24 hours to prevent atrophy of muscle fibers in rats with sciatic nerve transection. Other studies in healthy humans showed that 40 to 80 contractions performed in a single session promoted significant results in gaining strength and muscle volume [47, 48] . Thus, different from other published studies with critically ill patients (average of 40 minutes of treatment and 300 contractions) [4, 5, [15] [16] [17] [18] [19] [20] [21] [22] , we performed only 15 minutes of NMES which evoked 90 contractions. The average time to stimulate the 5 muscle groups with this protocol (taking into consideration the electrode positioning, stimulus electrodiagnosis test, and NMES sessions) was 107 ± 24 minutes. This fact may hinder the application of this protocol in clinical practice, because the time available for professionals to treat each patient is restricted. In the present protocol, we used conductive silicon electrode, which is different from adhesive electrodes and it is more time demanding for setting up on the skin. It increased significantly the total procedure time. Kho et al [21] consumed 53 (±11) minutes to perform NMES protocol in 3 muscles groups. Nevertheless, these authors did not carry out stimulus electrodiagnosis test and they treated lesser muscles groups than in the present study. However, we have demonstrated Fig. 5 . Serum lactate and venous oxygen saturation variations before and after NMES. A, No statistical difference over the days before and after NMES: day 1: P = .79; day 2: P = .5; day 3: P = .88. B, No statistical difference on days 1 and 2 before and after NMES. However, there was significant variation on day 3 with increased SvcO 2 after NMES: day 1: P = .23; day 2: P = .24; day 3: P = .01. All analyses were performed with Wilcoxon signed rank test. the feasibility of our protocol. We detected higher success treatment sessions than previous publication [5, 21, 26, 28] with 100% of visible muscle contraction. Segers et al [26] detected adequate quadriceps contraction only in 50% of patients. Rodriguez et al [5] detected adequate quadriceps contraction in 77% of NMES sessions and Kho et al [21] in 87%. We could have better results because of larger pulse width, which increased the total charge and/or because of the presence of severe patients with less severe state in our sample. Further studies should be performed to understand better the effect of these factors. The major cause to stop session, which occurred in 15% cases, was due to pain.
The main advantage of this study was that it demonstrated that an NMES protocols based on chronaxie values and performed with higher level of total charge on large muscle volume is safe. The number of channels available in the stimulator and the use of silicon conductive electrodes limited our study. Channel numbers precluded the application of NMES in all muscle groups at the same time. Also, the maximum intensity available on the equipment reached only 69 mA. Because of neuromuscular electrophysiological disorders and edema, some patients needed more charge [49] . All our patients had muscle contraction with the present NMES protocol, but we perceived in some cases that a more powerful contraction could be reached if a higher intensity would be used. Thus, a device with at least 150 mA may be required to treat such patients. Moreover, it was assessed in a very specific population (majorly polytrauma patients with low Acute Physiology and Chronic Health Evaluation II score) that limits extrapolation of our results to general critical ill patients with more severe state. Future randomized controlled trials are necessary to assess the effectiveness of the present protocol and the possibility of using NMES equipment able to treat all muscle groups simultaneously in different populations.
Conclusion
The present NMES protocol performed in 5 muscle groups and based on neuromuscular excitability applied in critically ill patients undergoing mechanical ventilation was safe. Despite being a time-demanding procedure, the feasibility of our protocol was shown. The differences in neuromuscular excitability among muscles and between patients demonstrated the possibility for using customized NMES protocols based on chronaxie.
